Transcriptome profiling in Parkinson's leukocytes: From early diagnostics to neuroimmune therapeutic prospects

Current Opinion in Pharmacology

Volumn 26, Issue , 2016, Pages 102-109

  Simchovitz, Alon ^a   Soreq, Lilach ^b   Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; LEUKOCYTE; METABOLISM; PARKINSON DISEASE; SEQUENCE ANALYSIS;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSON DISEASE; SEQUENCE ANALYSIS, RNA;

EID: 84947556247     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.10.007     Document Type: Review

References (73)

1. K. Wirdefeldt, H.O. Adami, P. Cole, D. Trichopoulos, and J. Mandel Epidemiology and etiology of Parkinson's disease: a review of the evidence Eur J Epidemiol 26 Suppl. 1 2011 S1 S58
2. L. Fontana, B.K. Kennedy, V.D. Longo, D. Seals, and S. Melov Medical research: treat ageing Nature 511 2014 405 407
3. S. Lesage, and A. Brice Parkinson's disease: from monogenic forms to genetic susceptibility factors Hum Mol Genet 18 2009 R48 R59
4. C. Pont-Sunyer, A. Hotter, C. Gaig, K. Seppi, Y. Compta, R. Katzenschlager, N. Mas, D. Hofeneder, T. Brucke, A. Bayes, and et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study) Mov Disord 30 2015 229 237
5. K.G. Lloyd, L. Davidson, and O. Hornykiewicz The neurochemistry of Parkinson's disease: effect of L-dopa therapy J Pharmacol Exp Ther 195 1975 453 464
6. L. Brichta, P. Greengard, and M. Flajolet Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems Trends Neurosci 36 2013 543 554
7. N. Maurice, M. Liberge, F. Jaouen, S. Ztaou, M. Hanini, J. Camon, K. Deisseroth, M. Amalric, L. Kerkerian-Le Goff, and C. Beurrier Striatal cholinergic interneurons control motor behavior and basal ganglia function in experimental Parkinsonism Cell Rep 2015
8. A.L. Benabid, S. Chabardes, J. Mitrofanis, and P. Pollak Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease Lancet Neurol 8 2009 67 81
9. W.M. Schuepbach, J. Rau, K. Knudsen, J. Volkmann, P. Krack, L. Timmermann, T.D. Halbig, H. Hesekamp, S.M. Navarro, N. Meier, and et al. Neurostimulation for Parkinson's disease with early motor complications N Engl J Med 368 2013 610 622
10. M. Deleidi, and T. Gasser The role of inflammation in sporadic and familial Parkinson's disease Cell Mol Life Sci 70 2013 4259 4273
11. D.G. Healy, M. Falchi, S.S. O'Sullivan, V. Bonifati, A. Durr, S. Bressman, A. Brice, J. Aasly, C.P. Zabetian, S. Goldwurm, and et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study Lancet Neurol 7 2008 583 590
12. J. Blesa, S. Phani, V. Jackson-Lewis, and S. Przedborski Classic animal models of Parkinson's disease J Biomed Biotechnol 2012 2012 845618 845620
13. L. Soreq, Y. Ben-Shaul, Z. Israel, H. Bergman, and H. Soreq Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways Neurobiol Dis 45 2012 1018 1030
14. W.S. Kim, K. Kagedal, and G.M. Halliday Alpha-synuclein biology in Lewy body diseases Alzheimers Res Ther 6 2014 73
15. J.S. Pachter, H.E. de Vries, and Z. Fabry The blood-brain barrier and its role in immune privilege in the central nervous system J Neuropathol Exp Neurol 62 2003 593 604
16. T.H. Hamza, C.P. Zabetian, A. Tenesa, A. Laederach, J. Montimurro, D. Yearout, D.M. Kay, K.F. Doheny, J. Paschall, E. Pugh, and et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease Nat Genet 42 2010 781 785
17. E. Pascale, E. Passarelli, C. Purcaro, A.R. Vestri, A. Fakeri, R. Guglielmi, F. Passarelli, and G. Meco Lack of association between IL-1 beta TNF-alpha, and IL-10 gene polymorphisms and sporadic Parkinson's disease in an Italian cohort Acta Neurol Scand 124 2011 176 181
18. L. Benmoyal-Segal, and H. Soreq Gene-environment interactions in sporadic Parkinson's disease J Neurochem 97 2006 1740 1755
19. T. Raj, K. Rothamel, S. Mostafavi, C. Ye, M.N. Lee, J.M. Replogle, T. Feng, M. Lee, N. Asinovski, I. Frohlich, and et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes Science 344 2014 519 523
20. V. Grozdanov, C. Bliederhaeuser, W.P. Ruf, V. Roth, K. Fundel-Clemens, L. Zondler, D. Brenner, A. Martin-Villalba, B. Hengerer, J. Kassubek, and et al. Inflammatory dysregulation of blood monocytes in Parkinson's disease patients Acta Neuropathol 128 2014 651 663
21. M. Reale, C. Iarlori, A. Thomas, D. Gambi, B. Perfetti, M. Di Nicola, and M. Onofrj Peripheral cytokines profile in Parkinson's disease Brain Behav Immun 23 2009 55 63
22. W.C. Lin, N.W. Tsai, Y.C. Huang, K.Y. Cheng, H.L. Chen, S.H. Li, C.T. Kung, Y.J. Su, W.M. Lin, M.H. Chen, and et al. Peripheral leukocyte apoptosis in patients with Parkinsonism: correlation with clinical characteristics and neuroimaging findings Biomed Res Int 2014 2014 635923
23. N. Funk, P. Wieghofer, S. Grimm, R. Schaefer, H.J. Buhring, T. Gasser, and S. Biskup Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease Mov Disord 28 2013 392 395
24. C. D'Mello, T. Le, and M.G. Swain Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation J Neurosci 29 2009 2089 2102
25. J. Thevenet, R. Pescini Gobert, R. Hooft van Huijsduijnen, C. Wiessner, and Y.J. Sagot Regulation of LRRK2 expression points to a functional role in human monocyte maturation PLoS One 6 2011 e21519
26. H. Soreq Checks and balances on cholinergic signaling in brain and body function Trends Neurosci 38 2015 448 458
27. B. Zheng, Z. Liao, J.J. Locascio, K.A. Lesniak, S.S. Roderick, M.L. Watt, A.C. Eklund, Y. Zhang-James, P.D. Kim, M.A. Hauser, and et al. PGC-1 alpha, a potential therapeutic target for early intervention in Parkinson's disease Sci Transl Med 2 2010 52ra73
28. S. Gollamudi, A. Johri, N.Y. Calingasan, L. Yang, O. Elemento, and M.F. Beal Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease PLoS One 7 2012 e36191
29. L. Soreq, Z. Israel, H. Bergman, and H. Soreq Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients J Neuroimmunol 201 202 2008 227 236
30. E. Minones-Moyano, M.R. Friedlander, J. Pallares, B. Kagerbauer, S. Porta, G. Escaramis, I. Ferrer, X. Estivill, and E. Marti Upregulation of a small vault RNA (svtRNA2-1 a) is an early event in Parkinson disease and induces neuronal dysfunction RNA Biol 10 2013 1093 1106
31. E. Minones-Moyano, S. Porta, G. Escaramis, R. Rabionet, S. Iraola, B. Kagerbauer, Y. Espinosa-Parrilla, I. Ferrer, X. Estivill, and E. Marti MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34 b/c which modulate mitochondrial function Hum Mol Genet 20 2011 3067 3078
32. L. Soreq, N. Salomonis, M. Bronstein, D.S. Greenberg, Z. Israel, H. Bergman, and H. Soreq Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes Front Mol Neurosci 6 2013 10
33. L.F. Cardo, E. Coto, R. Ribacoba, M. Menendez, G. Moris, E. Suarez, and V. Alvarez MiRNA profile in the substantia nigra of Parkinson's disease and healthy subjects J Mol Neurosci 54 2014 830 836
34. L. Soreq, A. Guffanti, N. Salomonis, A. Simchovitz, Z. Israel, H. Bergman, and H. Soreq Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing PLoS Comput Biol 10 2014 e1003517
35. B. Lu, S. Gehrke, and Z. Wu RNA metabolism in the pathogenesis of Parkinsons disease Brain Res 1584 2014 105 115
36. M.P. van der Brug, J. Blackinton, J. Chandran, L.Y. Hao, A. Lal, K. Mazan-Mamczarz, J. Martindale, C. Xie, R. Ahmad, K.J. Thomas, and et al. RNA binding activity of the recessive Parkinsonism protein DJ-1 supports involvement in multiple cellular pathways Proc Natl Acad Sci U S A 105 2008 10244 10249
37. L. Soreq, H. Bergman, Z. Israel, and H. Soreq Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes Neurodegener Dis 10 2012 203 206
38. L. Soreq, H. Bergman, Z. Israel, and H. Soreq Overlapping molecular signatures in Parkinson's patients' leukocytes before and after treatment and in mouse model brain regions CNS Neurol Disord Drug Targets 12 2013 1086 1093
39. L. Soreq, H. Bergman, Z. Israel, and H. Soreq Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytes BMC Genomics 14 2013 478
40. L. Soreq, N. Salomonis, Z. Israel, H. Bergman, and H. Soreq Analyzing alternative splicing data of splice junction arrays from Parkinson patients' leukocytes before and after deep brain stimulation as compared with control donors Genomics Data 5 2015 340 343
41. L. Soreq, H. Bergman, Y. Goll, D.S. Greenberg, Z. Israel, and H. Soreq Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes J Cell Mol Med 16 2012 1496 1507
42. C.R. Scherzer, A.C. Eklund, L.J. Morse, Z. Liao, J.J. Locascio, D. Fefer, M.A. Schwarzschild, M.G. Schlossmacher, M.A. Hauser, J.M. Vance, and et al. Molecular markers of early Parkinson's disease based on gene expression in blood Proc Natl Acad Sci U S A 104 2007 955 960
43. I. Gallego Romero, A.A. Pai, J. Tung, and Y. Gilad RNA-seq: impact of RNA degradation on transcript quantification BMC Biol 12 2014 42
44. S. Zhao, W.P. Fung-Leung, A. Bittner, K. Ngo, and X. Liu Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells PLoS One 9 2014 e78644
45. J.A. Santiago, and J.A. Potashkin Network-based metaanalysis identifies HNF4 A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease Proc Natl Acad Sci U S A 112 2015 2257 2262
46. A. Guffanti, A. Simchovitz, and H. Soreq Emerging bioinformatics approaches for analysis of NGS-derived coding and non-coding RNAs in neurodegenerative diseases Front Cell Neurosci 8 2014 89
47. J. Zhang, S. Li, L. Li, M. Li, C. Guo, J. Yao, and S. Mi Exosome and exosomal microRNA: trafficking, sorting, and function Genomics Proteomics Bioinformatics 13 2015 17 24
48. T. Botta-Orfila, X. Morato, Y. Compta, J.J. Lozano, N. Falgas, F. Valldeoriola, C. Pont-Sunyer, D. Vilas, L. Mengual, M. Fernandez, and et al. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease J Neurosci Res 92 2014 1071 1077
49. K. Burgos, I. Malenica, R. Metpally, A. Courtright, B. Rakela, T. Beach, H. Shill, C. Adler, M. Sabbagh, S. Villa, and et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology PLOS ONE 9 2014 e94839
50. E. Masliah, W. Dumaop, D. Galasko, and P. Desplats Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes Epigenetics 8 2013 1030 1038
51. Y.Y. Tan, L. Wu, Z.B. Zhao, Y. Wang, Q. Xiao, J. Liu, G. Wang, J.F. Ma, and S.D. Chen Methylation of alpha-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients Parkinsonism Relat Disord 20 2014 308 313
52. Y. Song, H. Ding, J. Yang, Q. Lin, J. Xue, Y. Zhang, P. Chan, and Y. Cai Pyrosequencing analysis of SNCA methylation levels in leukocytes from Parkinson's disease patients Neurosci Lett 569 2014 85 88
53. T. Alberio, K. McMahon, M. Cuccurullo, L.A. Gethings, C. Lawless, M. Zibetti, L. Lopiano, J.P. Vissers, and M. Fasano Verification of a Parkinson's disease protein signature in T-lymphocytes by multiple reaction monitoring J Proteome Res 13 2014 3554 3561
54. M. Soler-Lopez, A. Zanzoni, R. Lluis, U. Stelzl, and P. Aloy Interactome mapping suggests new mechanistic details underlying Alzheimer's disease Genome Res 21 2011 364 376
55. C. Carrieri, A.R. Forrest, C. Santoro, F. Persichetti, P. Carninci, S. Zucchelli, and S. Gustincich Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease Front Cell Neurosci 9 2015 114
56. M. Cesana, D. Cacchiarelli, I. Legnini, T. Santini, O. Sthandier, M. Chinappi, A. Tramontano, and I. Bozzoni A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA Cell 147 2011 358 369
57. A.D. Bosson, J.R. Zamudio, and P.A. Sharp Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition Mol Cell 56 2014 347 359
58. N. Dehorter, G. Ciceri, G. Bartolini, L. Lim, I. del Pino, and O. Marin Tuning of fast-spiking interneuron properties by an activity-dependent transcriptional switch Science 349 2015 1216 1220
59. L. Brichta, W. Shin, V. Jackson-Lewis, J. Blesa, E.L. Yap, Z. Walker, J. Zhang, J.P. Roussarie, M.J. Alvarez, A. Califano, and et al. Identification of neurodegenerative factors using translatome-regulatory network analysis Nat Neurosci 18 2015 1325 1333
60. I. Kuperstein, E. Bonnet, H.A. Nguyen, D. Cohen, E. Viara, L. Grieco, S. Fourquet, L. Calzone, C. Russo, M. Kondratova, and et al. Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps Oncogenesis 4 2015 e160
61. P. Garcia-Esparcia, F. Llorens, M. Carmona, and I. Ferrer Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson's disease brain is region dependent Brain Pathol 24 2014 584 598
62. M. Prinz, and J. Priller Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease Nat Rev Neurosci 15 2014 300 312
63. V. Brochard, B. Combadiere, A. Prigent, Y. Laouar, A. Perrin, V. Beray-Berthat, O. Bonduelle, D. Alvarez-Fischer, J. Callebert, J.M. Launay, and et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease J Clin Invest 119 2009 182 192
64. R. Kortekaas, K.L. Leenders, J.C. van Oostrom, W. Vaalburg, J. Bart, A.T. Willemsen, and N.H. Hendrikse Blood-brain barrier dysfunction in parkinsonian midbrain in vivo Ann Neurol 57 2005 176 179
65. C. Depboylu, M.K. Schafer, O. Arias-Carrion, W.H. Oertel, E. Weihe, and G.U. Hoglinger Possible involvement of complement factor C1 q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease J Neuropathol Exp Neurol 70 2011 125 132
66. C. Kim, E. Rockenstein, B. Spencer, H.-K. Kim, A. Adame, M. Trejo, K. Stafa, H.-J. Lee, S.-J. Lee, and E. Masliah Antagonizing neuronal Toll-like receptor 2 prevents synucleinopathy by activating autophagy Cell Rep 2015
67. S. Zhang, X.J. Wang, L.P. Tian, J. Pan, G.Q. Lu, Y.J. Zhang, J.Q. Ding, and S.D. Chen CD200-CD200 R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease J Neuroinflammation 8 2011 154
68. A.M. Espinosa-Oliva, R.M. de Pablos, M. Sarmiento, R.F. Villaran, A. Carrillo-Jimenez, M. Santiago, J.L. Venero, A.J. Herrera, J. Cano, and A. Machado Role of dopamine in the recruitment of immune cells to the nigro-striatal dopaminergic structures Neurotoxicology 41 2014 89 101
69. J. Drouin-Ouellet, I. St-Amour, M. Saint-Pierre, J. Lamontagne-Proulx, J. Kriz, R.A. Barker, and F. Cicchetti Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease Int J Neuropsychopharmacol 2015 18
70. P.S. Whitton Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease Curr Opin Invest Drugs 11 2010 788 794
71. S. Darmanis, S.A. Sloan, Y. Zhang, M. Enge, C. Caneda, L.M. Shuer, M.G. Hayden Gephart, B.A. Barres, and S.R. Quake A survey of human brain transcriptome diversity at the single cell level Proc Natl Acad Sci U S A 112 2015 7285 7290
72. L. Mazutis, J. Gilbert, W.L. Ung, D.A. Weitz, A.D. Griffiths, and J.A. Heyman Single-cell analysis and sorting using droplet-based microfluidics Nat Protoc 8 2013 870 891
73. F.A. Ran, P.D. Hsu, C.Y. Lin, J.S. Gootenberg, S. Konermann, A.E. Trevino, D.A. Scott, A. Inoue, S. Matoba, Y. Zhang, and et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity Cell 154 2013 1380 1389